Topic: commercial manufacturing
Novartis has reupped with Recro Pharma's CMO for production of two drugs, plus other news.
Immunomedics says it will meet with the FDA to discuss the CRL it got for manufacturing, while Teva has a new union agreement in place.
Progenics last year picked up an FDA approval for its orphan radiotherapeutic. Now it has picked up a manufacturing facility to produce it in.
The Sandoz manufacturing network will be further 'optimized' as Novartis turns Sandoz into an autonomous unit in the next 18 months.
A small piece of a campus in New York that was once owned by Wyeth and then Pfizer will now become home to a small drugmaker.
Pfizer has formed a partnership to manufacture some of its drugs in the rapidly growing Asian market.
After more than a two-year delay, Portola will see the commercial release of Andexxa, a bleeding antidote for anticoagulants Xarelto and Eliquis.
Just months after announcing a $65 million expansion to boost capacity and jobs at its North Carolina facility, Novo says it needs more of both.
A Chinese maker of heparin and APIs for oncology and other drugs is investing nearly $150 million as it targets innovative drugs for China.
Sun Pharma is picking up two manufacturing plants and a portfolio of dermatology drugs in Japan for just $1 million.